{
    "eid": "2-s2.0-84971320923",
    "title": "Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450",
    "cover-date": "2016-06-01",
    "subject-areas": [
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        },
        {
            "$": "Pharmacology",
            "@code": "3004"
        },
        {
            "$": "Pharmaceutical Science",
            "@code": "3003"
        }
    ],
    "keywords": [
        "Cytochrome P450",
        "Drug interaction",
        "Induction",
        "Inhibition",
        "Phikud Navakot"
    ],
    "authors": [
        "Abhiruj Chiangsom"
    ],
    "citedby-count": 6,
    "ref-count": 28,
    "ref-list": [
        "List of Herbal Medicinal Products A.D. 2013",
        "Effects of Phikud Navakot extract on vascular reactivity in the isolated rat aorta",
        "Integr Med Res",
        "Afr J Biotechnol",
        "Chronic ingestion of high dosed Phikud Navakot extraction induces mesangiolysis in rats with alteration of AQP1 and Hsp60 expressions",
        "Guidance for Industry on Drug Interaction Studies: Study Design, Data Analysis, Implications for Dosing and Labeling Recommendations",
        "Validation of an RP-HPLC method for quantitative analysis of phikud navakot extract using the standard addition method",
        "Effects of silver nanoparticles on rat hepatic cytochrome P450 enzyme activity",
        "Preliminary Screening Test for the Effect of 5 Thai Herbal Crude Extracts (Artemisia Pallens, Ligusticum Chuanxiong, Dischidia Rafflesiana, Atractylodes Lancea, Plantago Ovate) on Rat CYP3A4 Enzyme Activity in Vitro",
        "Preliminary Screening Test for the Effect of Kote Sor and 4 Thai Herbal Extract on Rat CYP3A4 Enzyme Activity In-vitro",
        "Estimation of gallic acid, rutin and quercetin in terminalia chebula by hptlc",
        "Inhibition of CYP3A-mediated oxidation in human hepatic microsomes by the dietary derived complex phenol, gallic acid",
        "Interaction of drugs and Chinese herbs: Pharmacokinetic changes of tolbutamide and diazepam caused by extract of Angelica dahurica",
        "Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction",
        "Guidance for Industry on Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and Labeling",
        "Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes",
        "Effect of glimepiride and glibenclamide on S-warfarin 7-hydroxylation by human liver microsomes, recombinant human CYP2C9.1 and CYP2C9.3",
        "Short communication differential time- and NADPH-dependent inhibition of CYP2C19 by enantiomers of fluoxetine",
        "An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems.",
        "Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS/MS analysis",
        "Modulation of pharmacokinetics of theophylline by antofloxacin, a novel 8-amino-fluoroquinolone, in humans",
        "Clinical and toxicological relevance of CYP2C9: Drug-drug interactions and pharmacogenetics",
        "Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors",
        "Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes",
        "Reversible Inhibition: Drug Metabolism in Drug Design and Development",
        "Blood volume measurement at the bedside using ICG pulse spectrophotometry",
        "Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity",
        "Role of human cytochromes p450 in the metabolic activation of chemical carcinogens and toxins"
    ],
    "affiliation": [
        {
            "affiliation-city": "Nagoya",
            "affilname": "Nagoya University Graduate School of Medicine",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "affilname": "Thailand National Science and Technology Development Agency",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Department of Drug Safety Sciences",
        "Nagoya University Graduate School of Medicine , Nagoya, Japan",
        "National Nanotechnology",
        "Research, Development and Engineering Fund",
        "Chulalongkorn University",
        "National Science and Technology Development Agency",
        "National Research Council of Thailand",
        "National Research Council of Thailand"
    ]
}